These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes. Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819 [TBL] [Abstract][Full Text] [Related]
6. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419 [TBL] [Abstract][Full Text] [Related]
7. [Polyradiculoneuritis and Campylobacter jejuni: clinical and physiopathological aspects]. Diagana M; Khalil M; Preux PM; Dumas M; Jauberteau MO Med Trop (Mars); 2003; 63(1):68-74. PubMed ID: 12891754 [TBL] [Abstract][Full Text] [Related]
8. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Yuki N Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987 [TBL] [Abstract][Full Text] [Related]
10. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report]. Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419 [TBL] [Abstract][Full Text] [Related]
11. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis]. Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613 [TBL] [Abstract][Full Text] [Related]
12. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446 [TBL] [Abstract][Full Text] [Related]
13. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234 [TBL] [Abstract][Full Text] [Related]
14. The axon in Guillain-Barré syndrome: immune target or innocent bystander? Powell HC; Myers RR Ann Neurol; 1996 Jan; 39(1):4-5. PubMed ID: 8572665 [No Abstract] [Full Text] [Related]
15. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608 [TBL] [Abstract][Full Text] [Related]
16. Current concepts in Guillain-Barré syndrome. Franco DA; Bashir RM Nebr Med J; 1996 Dec; 81(12):406-11. PubMed ID: 9046790 [No Abstract] [Full Text] [Related]
17. The immunopathology of Guillain-Barré syndrome. Saida K Curr Opin Neurol; 1996 Oct; 9(5):329-33. PubMed ID: 8894406 [TBL] [Abstract][Full Text] [Related]
18. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y; Matsumoto Y; Yuki N No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308 [TBL] [Abstract][Full Text] [Related]
20. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M; Takahashi M; Masuda M; Hirata K; Yuki N Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]